首页> 外国专利> MODIFIED RELEASE DRUG POWDER COMPOSITION COMPRISING GASTRO-RETENTIVE RAFT FORMING SYSTEMS HAVING TRIGGER PULSE DRUG RELEASE

MODIFIED RELEASE DRUG POWDER COMPOSITION COMPRISING GASTRO-RETENTIVE RAFT FORMING SYSTEMS HAVING TRIGGER PULSE DRUG RELEASE

机译:具有触发式脉冲药物释放功能的包含胃固位筏形成系统的改良的释放药物粉末成分

摘要

An orally administrable drug powder composition which forms a gastro-retentive RAFT having at least two trigger pulses is provided. The composition contains, at a minimum, (a) at least one drug in an immediate release pulse release form; (b) at least one drug in a delayed trigger release form; (c) at least one non-toxic gas generating agent and (d) a RAFT system, wherein following oral ingestion, the composition provides a self- assembling gastro-retentive RAFT having entrapped therein, the at least one drug of (a) and (b) and the gas generated in situ by the non-toxic gas generating agent, thereby providing a floating gastro-retentive RAFT having a dual pulse system wherein at least the second pulse is a trigger pulse and which retains the at least one drug in the stomach for at least about 3 hours, provided that the composition does not include a gamma hydroxybutyrate and its salts, hydrates, tautomers, or solvates, or complexes thereof.
机译:提供了形成具有至少两个触发脉冲的胃滞留型RAFT的可口服给药的药物粉末组合物。该组合物至少包含(a)至少一种立即释放脉冲释放形式的药物; (b)至少一种延迟触发释放形式的药物; (c)至少一种无毒气体发生剂和(d)RAFT系统,其中在口服摄入后,该组合物提供了一种自组装的胃滞留型RAFT,其中包埋了(a)的至少一种药物和(b)和由无毒气体发生剂原位产生的气体,从而提供一种具有双脉冲系统的浮动胃滞留性RAFT,其中至少第二个脉冲是触发脉冲,并且将至少一种药物保留在如果组合物不包含γ-羟基丁酸酯及其盐,水合物,互变异构体或溶剂化物或它们的复合物,则在胃中至少约3小时。

著录项

  • 公开/公告号WO2019126218A1

    专利类型

  • 公开/公告日2019-06-27

    原文格式PDF

  • 申请/专利权人 TRIS PHARMA INC.;

    申请/专利号WO2018US66303

  • 申请日2018-12-18

  • 分类号A61K9;A61K9/10;A61K9/16;A61K9/50;A61K9/51;A61K47/58;

  • 国家 WO

  • 入库时间 2022-08-21 11:54:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号